VALIDATION AND REFINEMENT OF THE REVISED 2017 EUROPEAN LEUKEMIANET GENETIC RISK STRATIFICATION OF ACUTE MYELOID LEUKEMIA
The revised 2017 European LeukemiaNet (ELN) recommendations for genetic risk stratification of acute myeloid leukemia have been widely adopted, but have not yet been validated in large cohorts of AML patients. We studied 1116 newly diagnosed AML patients (age range, 18-86 years) who had received induction chemotherapy. Among 771 patients not selected by genetics, the […]
